Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Abstract The therapeutic benefits of the current medications for patients with psychiatric disorders contrast with a great variety of adverse…
Abstract The therapeutic benefits of the current medications for patients with psychiatric disorders contrast with a great variety of adverse…
Abstract Recently, a new class of psychedelic compounds named NBOMe (or 25X-NBOMe) has appeared on the illegal drug market. NBOMes…
Abstract New Psychoactive Substances (NPS) belong to several chemical classes, including phenethylamines, piperazines, synthetic cathinones and synthetic cannabinoids. Development and…